Cargando…
Long-Term Non-Cancer Risks in People with BRCA Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review
SIMPLE SUMMARY: People with BRCA mutations are at high risk for ovarian and breast cancer. In order to greatly reduce their risks of these cancers, people with BRCA mutations undergo surgery between the ages of 35–45 to remove both ovaries and fallopian tubes. However, this type of surgery results i...
Autores principales: | Nitschke, Amanda S., do Valle, Helena Abreu, Dawson, Lesa, Kwon, Janice S., Hanley, Gillian E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913268/ https://www.ncbi.nlm.nih.gov/pubmed/36765666 http://dx.doi.org/10.3390/cancers15030711 |
Ejemplares similares
-
Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence
por: Conduit, Ciara, et al.
Publicado: (2021) -
Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm
por: Gasparri, Maria Luisa, et al.
Publicado: (2019) -
Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
por: Schrauder, Michael G., et al.
Publicado: (2019) -
Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause
por: Manchanda, R, et al.
Publicado: (2022) -
Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy
por: Johansen, Nora, et al.
Publicado: (2018)